Endogenous tumor necrosis factor alpha is required for enhanced antimicrobial activity against Toxoplasma gondii and Listeria monocytogenes in recombinant gamma interferon-treated mice.
about
A tumor necrosis factor mimetic peptide activates a murine macrophage cell line to inhibit mycobacterial growth in a nitric oxide-dependent fashionInterleukin-10 has different effects on proliferation of Listeria monocytogenes in livers and spleens of mice.Exacerbated susceptibility to infection-stimulated immunopathology in CD1d-deficient mice.Mycobacterial 65-kilodalton heat shock protein induces tumor necrosis factor alpha and interleukin 6, reactive nitrogen intermediates, and toxoplasmastatic activity in murine peritoneal macrophagesAcquired resistance against a secondary infection with Listeria monocytogenes in mice is not dependent on reactive nitrogen intermediatesCR3-dependent resistance to acute Toxoplasma gondii infection in mice.Tumor necrosis factor alpha and interleukin-12 contribute to resistance to the intracellular bacterium Brucella abortus by different mechanismsExpression pattern and cellular origin of cytokines in the normal and Toxoplasma gondii-infected murine brain.Granulocyte-macrophage colony-stimulating factor is not involved in production of reactive nitrogen intermediates by or toxoplasmastatic activity of gamma interferon-activated murine macrophagesDifferent subsets of T cells in conjunction with natural killer cells, macrophages, and activated microglia participate in the intracerebral immune response to Toxoplasma gondii in athymic nude and immunocompetent rats.Differential expression of tumor necrosis factor and interleukin-6 by peritoneal macrophages in vivo and in culture.Transgenic mice in the study of cytokine functionPathogenesis and immune responses in gnotobiotic calves after infection with the genogroup II.4-HS66 strain of human norovirus.Cytokine gene expression in mice at an early stage of infection with various strains of Listeria spp. differing in virulence.Interleukin-12, dendritic cells, and the initiation of host-protective mechanisms against Toxoplasma gondiiImmunopathological aspects of experimental Trypanosoma cruzi reinfections.
P2860
Q33753828-D15FE411-0048-4E63-A041-C6FED37977A6Q34007827-FB5B0D18-562C-4F25-9C76-123882C12A34Q34440132-42506748-4781-49F6-94C5-58B98B932A80Q35436281-03038BC6-7AB4-4D8F-9233-9346D9A5296BQ35480633-18FB7585-5BE5-44CD-A4D2-3231672BCCF1Q35495536-2A0CF17C-1BE3-4FBE-BDFF-A6647E06ADC4Q35506571-EA0E376D-EF3D-4B39-B714-3D77112C9E43Q35763523-9F2E5366-C411-4D7C-9221-96740F598013Q35775599-A6B7F93B-D28B-4FC0-A84E-87EBD5DFF9A3Q35795022-D632FD9B-27B7-4C2B-A731-E498E40CE85AQ35833222-573CE8E2-880F-476A-81DD-90C19A14767DQ36029215-CE0731CE-B400-4E81-99B6-E30516CF133AQ36483283-74B3CFFB-D509-456E-90F6-84CFA43C822EQ40375120-8D5E4CE9-ED13-46FE-97AC-F7ABFB0242E1Q41870467-B0CBDF31-5F16-4533-9BBE-3AA077AE7CB1Q42733135-5FA1C078-4438-4418-9A7D-45A233602E82
P2860
Endogenous tumor necrosis factor alpha is required for enhanced antimicrobial activity against Toxoplasma gondii and Listeria monocytogenes in recombinant gamma interferon-treated mice.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Endogenous tumor necrosis fact ...... gamma interferon-treated mice.
@en
type
label
Endogenous tumor necrosis fact ...... gamma interferon-treated mice.
@en
prefLabel
Endogenous tumor necrosis fact ...... gamma interferon-treated mice.
@en
P2093
P2860
P1476
Endogenous tumor necrosis fact ...... gamma interferon-treated mice
@en
P2093
Langermans JA
Nibbering PH
van Furth R
van der Hulst ME
P2860
P304
P407
P577
1992-12-01T00:00:00Z